NCT03974347

Brief Summary

The investigators intend to study 2 new methods for the early detection of Acute Kidney Injury (AKI) after cardiac surgery and compare and combine the predictive abilities of these methods with established renal injury markers and epidemiological models to detect (AKI).

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
3mo left

Started Jan 2025

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Jan 2025Sep 2026

First Submitted

Initial submission to the registry

June 2, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2019

Completed
5.6 years until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

September 3, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

June 2, 2019

Last Update Submit

August 26, 2025

Conditions

Keywords

cardiac surgeryrenal resistive indexcreatinine clearance

Outcome Measures

Primary Outcomes (1)

  • Acute Kidney Injury

    Acute Kidney Injury defined by KDiGO criteria

    48 hours

Secondary Outcomes (1)

  • 30 day Mortality

    30 days

Study Arms (2)

Acute kidney injury, no acute kidney injury

Acute kidney injury after cardiac surgery will be defined by KDIGO criteria, Creatinine rise from baseline and or urine production.

No Acute Kidney Injury

No Acute kidney Injury after Cardiac surgery, according to KDIGO AKI definition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elective cardiac surgery patients undergoing surgery at Karolinska University Hospital, Sweden. Patients with high risk for AKI as identified by the Clevland Clinic acute renal failure score will be identified.

You may qualify if:

  • years and older
  • Undergoing elective cardiac surgery (Coronary artery bypass grafting, valve surgery, aortic surgery or a combination).
  • Able to understand and give written consent to partake in the study

You may not qualify if:

  • Unable to give consent
  • Previously received a renal transplant
  • Renal failure requiring dialysis prior to surgery
  • Persistent atrial fibrillation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789. Epub 2012 Aug 7. No abstract available.

    PMID: 22890468BACKGROUND
  • Le Dorze M, Bougle A, Deruddre S, Duranteau J. Renal Doppler ultrasound: a new tool to assess renal perfusion in critical illness. Shock. 2012 Apr;37(4):360-5. doi: 10.1097/SHK.0b013e3182467156.

    PMID: 22258233BACKGROUND
  • Ryden L, Ahnve S, Bell M, Hammar N, Ivert T, Sartipy U, Holzmann MJ. Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death. Int J Cardiol. 2014 Mar 1;172(1):190-5. doi: 10.1016/j.ijcard.2014.01.013. Epub 2014 Jan 22.

    PMID: 24502882BACKGROUND
  • Hertzberg D, Ceder SL, Sartipy U, Lund K, Holzmann MJ. Preoperative Renal Resistive Index Predicts Risk of Acute Kidney Injury in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2017 Jun;31(3):847-852. doi: 10.1053/j.jvca.2016.10.006. Epub 2016 Oct 11.

    PMID: 28017677BACKGROUND
  • Ryden LC, Sartipy U, Holzmann MJ. Acute Kidney Injury After Surgical AVR and Long-Term Risk of Death and End-Stage Renal Disease. J Am Coll Cardiol. 2015 Nov 17;66(20):2263-2264. doi: 10.1016/j.jacc.2015.08.883. No abstract available.

    PMID: 26553408BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood and Urine samples will be obtained. The following biomarkers will be measured NGAL, TIMP-2, IGFBP7, KIM-1, IL-18, L-FABP, cystatin C och angiotensinogen. Renal function markers Creatinine and urea will also be measured.

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Max Bell, MD, PHD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR
  • Daniel Hertberg, MD, PHD

    Karolinska Institutet

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 2, 2019

First Posted

June 4, 2019

Study Start

January 1, 2025

Primary Completion

September 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

September 3, 2025

Record last verified: 2025-08